At Least 58 Have Now Been Sickened After Eating Diamond Shruumz Edibles

Follow Drugslib on

Medically reviewed by Drugs.com.

By Robin Foster HealthDay Reporter

THURSDAY, July 11, 2024 -- Nearly 60 illnesses, including 30 hospitalizations, have now been linked to eating Diamond Shruumz edibles, U.S. health officials reported.

The U.S. Centers for Disease Control and Prevention noted in an update issued Tuesday that of the people who got sick after eating the recalled chocolate bars, cones and gummies, one patient has died.

Those who fell ill reported seizures, agitation, abnormal heart rates and loss of consciousness. So far, 27 states have reported cases, but the CDC said it expects that number to grow.

While the CDC hasn't disclosed how many of the cases have involved youths, at least two children have been hospitalized in Arizona, a spokesperson for the Banner Health system told CBS News. Two more children were exposed to the product, but were deemed only "mild" cases.

Banner Health was among the first to warn of the dangers posed by the Diamond Shruumz products, when patients were hospitalized after eating them, CBS News reported.

"We've seen the same phenomenon of people eating the chocolate bar then seizing, losing consciousness and having to be intubated," Steve Dudley, head of the Arizona Poison and Drug Information Center, told CBS News.

Late last month, the company that makes the edibles issued a full recall of all its products after discovering high levels of a mushroom toxin in the products.

The recall was issued "because such products contain muscimol, a chemical found in mushrooms of the genus amanita," California-based Prophet Premium Blends stated in its announcement.

"Muscimol could be a potential cause of symptoms consistent with those observed in persons who became ill after eating Diamond Shruumz products," the company added. Reported symptoms include seizures, agitation, involuntary muscle contractions, loss of consciousness, confusion, sleepiness, nausea and vomiting, abnormal heart rates and high/low blood pressure.

States with cases include Alabama, Arizona, California, Colorado, Florida, Georgia, Indiana, Iowa, Kentucky, Maryland, Minnesota, Missouri, Montana, Nevada, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas and Virginia.

The FDA first advised consumers not to eat Diamond Shruumz microdosing chocolate bars several weeks ago, warning that people in four states had fallen ill. Some had to be intubated.

The recalled products were distributed nationwide through retail stores and mail order.

Back in late May, Prophet Premium received the first two complaints of people becoming ill after eating an entire chocolate bar. That prompted the company to conduct an analysis of its ingredients, which "showed higher than normal amounts of muscimol," the recall notice said.

The company said it has stopped producing and distributing the Diamond Shruumz product line while it and the FDA continue to investigate the cause of the illnesses.

Consumers who bought Diamond Shruumz products should stop using them and contact the company at 209-314-0881 or by email at [email protected] with their order number to get a refund.

Sources

  • U.S. Centers for Disease Control and Prevention, health update, July 9, 2024
  • U.S. Food and Drug Administration, health alert, July 2, 2024
  • CBS News

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-07-11 23:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords

    AI Assitant